European Centre for Disease Prevention and Control. (2019) Hepatitis C - annual epidemiological report for 2017. Solna: European Centre for Disease Prevention and Control.
Preview | Title | Contact |
---|---|---|
|
PDF (Hepatitis C - annual epidemiological report for 2017)
- Published Version
777kB |
Key facts
- In 2017, 31 273 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases, 31 178 cases corresponds to a crude rate of 7.3 cases per 100 000 population.
- Of the cases reported, 3% were classified as acute, 22% as chronic and 75% as ‘unknown’.
- Hepatitis C was more commonly reported among men than women, with a male-to-female ratio of 1.6:1. The most affected age group among males was between 35–44 years and for females between 25–34 years.
- Mode of transmission was reported for 26% of cases. The most commonly reported mode was injecting drug use, which accounted for 44% of cases with complete information on transmission status.
- The interpretation of hepatitis C notification data across countries remains problematic, with ongoing differences in surveillance systems and difficulties in defining reported cases as acute or chronic. With hepatitis C, a largely asymptomatic disease until the late stages, surveillance based on notification data is challenging, with data reflecting testing practices rather than true occurrence of disease.
Item Type
Report
Publication Type
Irish-related, International, Report
Drug Type
Substances (not alcohol/tobacco), Opioid
Intervention Type
Harm reduction, Screening / Assessment
Date
April 2019
Pages
9 p.
Publisher
European Centre for Disease Prevention and Control
Corporate Creators
European Centre for Disease Prevention and Control
Place of Publication
Solna
EndNote
Accession Number
HRB (Electronic Only)
Related (external) link
Subjects
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
J Health care, prevention, harm reduction and treatment > Risk and protective factors > Risk factors
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe
VA Geographic area > Europe > Ireland
J Health care, prevention, harm reduction and treatment > Risk and protective factors > Risk factors
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page